Roivant Sciences Ltd.
Close on Nov 18, 2026Market cap $27.98BP/E –Yield –
Roivant Sciences Covant Therapeutics — Basic Ownership Stake by Quarter
Covant Therapeutics — Basic Ownership Stake (%)
Roivant Sciences Covant Therapeutics — Basic Ownership Stake: 96.0% in Q2 FY2026, up 1.0 pts from a year earlier.
Where the Q2 FY2026 figure comes from
“|| Covant | 96 | % | 90 | %”
Source: Form 10-Q (roiv-20260930.htm, filed 2026-11-09) ↗
Reported in Form 10-K / 10-Q (Roivant Ownership Table).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up covant Therapeutics — Basic Ownership Stake
Cite this data
StockData. (2026). Roivant Sciences Covant Therapeutics — Basic Ownership Stake (%), quarterly Q2 FY2022–Q2 FY2026 [Data set]. Compiled from Roivant Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/roiv/kpis/own-covant-basic
See every metric in the Roivant Sciences KPI table. Data updated Nov 16, 2026.
See a number that looks wrong?